Announcements Trials

Browse Landscape

Phase

Phase 2 7 Phase 1/2 2 Phase 3 1 Phase 1 1

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Carcinoma, Non-Small-Cell Lung 24 Squamous Cell Carcinoma of Head and Neck 11 Small Cell Lung Carcinoma 11 Lung Neoplasms 11 Neoplasm Metastasis 10 Carcinoma, Hepatocellular 9 Breast Neoplasms 9 Ovarian Neoplasms 8 Colorectal Neoplasms 8 Triple Negative Breast Neoplasms 7 Pancreatic Neoplasms 7 Advanced Solid Tumors 7 Melanoma 6 Biliary Tract Neoplasms 6 Urinary Bladder Neoplasms 5 Uterine Cervical Neoplasms 4 Prostatic Neoplasms 4 Neoplasms 4 Lymphoma, Large B-Cell, Diffuse 4 Cholangiocarcinoma 4 Carcinoma, Renal Cell 4 Stomach Neoplasms 3 Recurrence 3 Multiple Myeloma 3 Head and Neck Neoplasms 3 Diabetes Mellitus, Insulin-Dependent, 12 3 Advanced Solid Tumours 3 Vulvar Neoplasms 2 Vaginal Neoplasms 2 Solid Tumor 2

Interventions

pembrolizumab 26 Nivolumab 18 enfortumab vedotin 7 avelumab 6 atezolizumab 6 Ipilimumab 6 Magnetic Resonance Spectroscopy 5 fludarabine 4 cabozantinib 4 Gemcitabine 4 Cyclophosphamide 4 Carboplatin 4 Specimen Handling 3 Interleukin-2 3 Docetaxel 3 130-nm albumin-bound paclitaxel 3 aldesleukin 2 Platinum 2 Pemetrexed 2 Paclitaxel 2 Oxaliplatin 2 Immunoglobulin G 2 Fluorodeoxyglucose F18 2 FAPI-46 2 Disulfides 2 Cisplatin 2 Albumin-Bound Paclitaxel 2 vinflunine 1 veliparib 1 valrubicin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Carcinoma, Transitional Cell × durvalumab × Clear all

NCT05154994 2026-05-07

RESOLVE

University of Utah

Phase 1 Active not recruiting

Carcinoma, Transitional Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡